Insights from 2023 SABCS


 

SABCS 2023 Insights: "HER2CLIMB-05 Trial - Tucatinib or Placebo in Combination With Trastuzumab & Pertuzumab as Maintenance Therapy for HER2+ mBC"

260 views
December 19, 2023
Comments 0
Login to view comments. Click here to Login